Clinical trial
Treatment of Multiple Sclerosis With Copaxone and Albuterol
NCT00039988 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00039988 |
|---|---|
| Title | Treatment of Multiple Sclerosis With Copaxone and Albuterol |
| Official title | Treatment of Multiple Sclerosis With Copaxone (Glatiramer Acetate) and Albuterol |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Autoimmunity Centers of Excellence |
| Status | Completed |
| Study type | Interventional |
| Conditions | Autoimmune Diseases, Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | Glatiramer acetate, Albuterol, Albuterol placebo |
| Enrollment | 40 |
| Start date | Nov 1, 2001 |
| Primary completion | Mar 1, 2006 |
| Completion | Nov 1, 2007 |
| First posted | Jun 20, 2002 |
| Last update posted | Sep 22, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: